Drug profile · INN
candesartan + hydrochlorothiazide
ATACAND PLUS 16/12.5
candesartan + hydrochlorothiazide (ATACAND PLUS 16/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — candesartan + hydrochlorothiazide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
candesartan + hydrochlorothiazide (ATACAND PLUS 16/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is candesartan + hydrochlorothiazide?
candesartan + hydrochlorothiazide (ATACAND PLUS 16/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
What is the brand name for candesartan + hydrochlorothiazide?
ATACAND PLUS 16/12.5 is a marketed brand name for candesartan + hydrochlorothiazide. Check FDA Drugs@FDA for the current US label holder and prescribing information.